oral tirzepatide efficacy Safety and of as an add-on to single antihyperglycaemic medication in patients with type 2 diabetes in Japan (SURPASS J-combo): a multicentre, randomised, open-label, parallel-group, phase 3 trial Tirzepatide (Mounjaro) for the Treatment

US Holds Largest Share in North America Driven by High Healthcare Spending The US GLP-1 receptor agonist market held the largest share in North America in 2025 due to its patient population, favorable regulatory environment, and high healthcare spending per capita

The study highlighted: "The appetite-suppressing effects of GLP-1 drugs are likely to prompt targeted adjustments in product development and packaging

Vlatkovic, I

GLP-1 medications mimic the effects of this hormone and influence several metabolic processes, including slowing gastric emptying, increasing feelings of fullness, reducing appetite, and improving blood sugar regulation